Loading clinical trials...
Loading clinical trials...
This is a double-blind, randomized, parallel group, dose ranging study of subcutaneous methylnaltrexone to be conducted in patients with advanced medical illness and poorly controlled opioid induced c...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bausch Health Americas, Inc.
NCT07213986 · Neurogenic Bowel Dysfunction, Spinal Cord Injury
NCT07511244 · Bladder and Bowel Dysfunction, SCI - Spinal Cord Injury
NCT06315179 · Inflammatory Bowel Diseases, Crohn Disease, and more
NCT05380856 · Neurogenic Dysfunction of the Urinary Bladder, Multiple Sclerosis, and more
NCT07369349 · Spinal Cord Injury, Neurogenic Bowel Dysfunction
Progenics Pharmaceuticals, Inc.
Tarrytown, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions